CAMBRIDGE, MA, Luminopia, a prescription digital therapeutics company, announced an oversubscribed $5.7M seed extension financing round.
Luminopia, Inc., a prescription digital therapeutics company pioneering a new class of treatments for neuro-visual disorders, today announced an oversubscribed $5.7M seed extension financing round. ShangBay Capital led the round, with participation from Sony Innovation Fund, The Vertical Group, and SSI Strategy, as well as support from existing investors.
(c) by Massinvestor, Inc. For contact info, please check out our
about page.
